Contravisory Investment Management, Inc. Amgen Inc Transaction History

Contravisory Investment Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $3.93 Million - $4.58 Million	-17,706 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $121,389 - $144,552	-561 Reduced 3.07%	17,706 $4.07 Million
Q3 2020 Oct 08, 2020	BUY	$234.65 - $260.95 $3.18 Million - $3.54 Million	13,562 Added 288.25%	18,267 $4.64 Million
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $930,696 - $1.14 Million	4,705 New	4,705 $1.07 Million
Q2 2019 Jul 09, 2019	SELL	$166.7 - $195.41 $43,175 - $50,611	-259 Closed	0 $0
Q4 2018 Jan 14, 2019	BUY	$178.4 - $208.25 $46,205 - $53,936	259 New	259 $50,000
Q4 2017 Jan 18, 2018	SELL	$168.79 - $188.59 $236,306 - $264,026	-1,400 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $234,206 - $267,400	1,400	1,400 $261,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.